Plasma brain derived neurotrophic factor levels and neuropsychological aspects of depressed patients treated with paroxetine.

Panminerva medica

Volumn 55, Issue 4, 2013, Pages 377-384

  Munno, D ^a   Sterpone, S ^b   Fania, S ^b   Cappellin, F ^b   Mengozzi, G ^b   Saroldi, M ^b   Bechon, E ^b   Zullo, G ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR, HUMAN; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; COGNITION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; TIME; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COGNITION; DEPRESSIVE DISORDER, MAJOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84903904648     PISSN: None     EISSN: 18271898     Source Type: Journal    
DOI: None     Document Type: Article

References (0)